Blue Water Ventures International, Inc.

Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences

Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space

Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.

Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing

Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD